Skip to main content

Biora Therapeutics, Inc.

BIORDelisted Jun 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001580063

Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.

13F holders, Q4 2024

Institutional positions in Biora Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

BIOR is no longer listed, and 13F filings after Q3 2024 list far fewer holders. See Q3 2024

Institutional holders
0
−20 vs. Q3 2024
Shares held
0
−1.29M (−100.0%) vs. Q3 2024
Total value
$0
−$644.7K (−100.0%) vs. Q3 2024
New holders
0
0 more added
Sold out
20
0 more reduced

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BIOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 0 institutions
Q1 2021: 48 institutionsQ2 2021: 42 institutionsQ3 2021: 36 institutionsQ4 2021: 57 institutionsQ1 2022: 55 institutionsQ2 2022: 49 institutionsQ3 2022: 47 institutionsQ4 2022: 48 institutionsQ1 2023: 32 institutionsQ2 2023: 31 institutionsQ3 2023: 25 institutionsQ4 2023: 30 institutionsQ1 2024: 28 institutionsQ2 2024: 29 institutionsQ3 2024: 21 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2024: $0
Q1 2021: $205.6MQ2 2021: $196.5MQ3 2021: $72.8MQ4 2021: $101.3MQ1 2022: $59.2MQ2 2022: $34.5MQ3 2022: $24.1MQ4 2022: $8.68MQ1 2023: $6.46MQ2 2023: $13.2MQ3 2023: $25.9MQ4 2023: $16.1MQ1 2024: $13.3MQ2 2024: $8.07MQ3 2024: $6.13MQ4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding BIOR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 202421$6.13M
Q2 202429$8.07M
Q1 202428$13.3M
Q4 202330$16.1M
Q3 202325$25.9M
Q2 202331$13.2M
Q1 202332$6.46M
Q4 202248$8.68M
Q3 202247$24.1M
Q2 202249$34.5M
Q1 202255$59.2M
Q4 202157$101.3M
Q3 202136$72.8M
Q2 202142$196.5M
Q1 202148$205.6M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Biora Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding BIOR in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc0$00.00%−697,330−100.0%Sold out
Geode Capital Management, LLC0$00.00%−156,298−100.0%Sold out
Morgan Stanley0$00.00%−145,028−100.0%Sold out
Northern Trust Corp0$00.00%−68,572−100.0%Sold out
BlackRock, Inc.0$00.00%−61,608−100.0%Sold out
State Street Corp0$00.00%−51,573−100.0%Sold out
HRT Financial LP0$00.00%−33,798−100.0%Sold out
XTX Topco Ltd0$00.00%−21,168−100.0%Sold out
LPL Financial LLC0$00.00%−20,704−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−16,792−100.0%Sold out
Barclays PLC0$00.00%−6,012−100.0%Sold out
Wells Fargo & Company0$00.00%−4,000−100.0%Sold out
Bank of America Corp0$00.00%−1,593−100.0%Sold out
TD Waterhouse Canada Inc.0$00.00%−1,120−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−647−100.0%Sold out
Riggs Asset Managment Co. Inc.0$00.00%−400−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−32−100.0%Sold out
JPMorgan Chase & Co0$00.00%−22−100.0%Sold out
Tucker Asset Management LLC0$00.00%−2−100.0%Sold out
Avion Wealth0$00.00%−1,500−100.0%Sold out
Athyrium Capital Management, LP––––Not filed